Novavax Inc (NVAX)
$10.08 -3.72% Close Oct 30, 2026 Live
Novavax stock today
Novavax closed at $10.08 on October 30, 2026, down 3.72% on the day. Over the past year it returned +19.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.66 billion.
$6.00$8.00$10.00$12.00
NovJan 2026MarMayJulSep
| Period | NVAX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -6.8% | -0.9% |
| 3 months | +35.5% | +2.1% |
| Year to date | +50.0% | +11.7% |
| 1 year | +19.6% | +12.4% |
| 3 years | +54.6% | +88.5% |
| 5 years | -93.2% | +76.0% |
Key statistics
- Market value
- $1.66B
- Price / sales
- 4.0
- 52-week range
- $6.22 to $12.82
- Next report
- Nov 5, 2026
About Novavax
Develops vaccines using recombinant nanoparticle technology for respiratory and infectious diseases.
Sector: Health Care
More on Novavax
- Financials: revenue, earnings and segmentsRevenue +65% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $350.00 today
No forecast, no recommendation. This page describes Novavax Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.